SeqWell is focused on simplifying sequencing technologies to accelerate next generation sequencing research. Their scientific focus centers on developing high-throughput sequencing platforms that improve the efficiency and accuracy of genomic analysis. SeqWell utilizes improved library preparation methods to enable quick turnaround and streamlined sequencing workflows. SeqWell aims to accelerate genomic research by helping researchers obtain high-quality plasmid and amplicon libraries to generate sequencing data that can help characterize a targeted gene or verify a plasmid. Their cutting-edge approach holds promise for advancing genomic sequencing capabilities and enhancing understanding of genetic variations and disease mechanisms through scientific innovation and technological advancement.

seqWell

Founded: 2014
Location: Beverly, MA
Employee range: 11 - 50
Funding: $9M B Jan 2020; $1.3M Jul 2016

Short description:

Drug notes:

Long description:

Jobs: